The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
 
CONTACT: DAVE PEDERSEN
283 Medical Laboratories
Iowa City IA 52242
(319) 335-8032; fax (319) 335-8034
e-mail: david-pedersen@uiowa.edu

Release: Immediate

Participants invited to join UI rheumatoid arthritis studies

IOWA CITY, Iowa -- Men and women age 18 and older are invited to participate in one of four University of Iowa College of Medicine studies of new medications to treat rheumatoid arthritis.

Adult men and women who have been diagnosed by a physician as having rheumatoid arthritis and have had the condition for at least six months are eligible to take part in one of the four UI studies. Researchers will investigate the effectiveness of four new medications in alleviating the pain and swelling associated with rheumatoid arthritis. The medications are TAK 603, VIOXX, Trocade and Samarium.

All research sessions will occur at the UI Hospitals and Clinics in Iowa City. For more information, call the Rheumatology Clinical Trials Unit at (319) 353-7087.

3/3/98